Literature DB >> 24291032

Evaluation of hemostatic activity of latex from three Euphorbiaceae species.

Shamkant B Badgujar1.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Latices from several plant species of Euphorbiaceae family have been traditionally applied over fresh cuts to stop bleeding and subsequently applied over wounds to enhance healing process. The latex arrested bleeding from fresh wounds by reducing bleeding and whole blood coagulation time which are important indices of hemostatic activity. It has been accepted that hemostatic activity is due to the proteolytic fraction of plant latices. Thus, the present study aimed to assess the clot inducing properties of three Euphorbiaceae plants viz., Euphorbia nivulia Buch.-Ham., Pedilanthus tithymaloides (L.) Poit and Synadenium grantii Hook F.
MATERIALS AND METHODS: In the present study, various proteolytic activities namely protease, gelatinase, milk clotting and whole blood clotting assay of the enzyme fraction of latices of Euphorbia nivulia, Pedilanthus tithymaloides and Synadenium grantii have been investigated. The inhibition profile of protease specific inhibitors was assessed. Also, the effects of protein fractions were studied using bleeding/clotting time test of fresh experimentally-induced wounds in mice.
RESULTS: Euphorbia nivulia latex protease has noticeable blood clotting activity followed by Pedilanthus tithymaloides and Synadenium grantii. Stem latex protease of Pedilanthus tithymaloides exhibits superior procoagulant activity in different mammal's blood samples viz., Capra hircus, Bubalus bubalis, Ovibos moschatus and Bos indicus. Blood sample of ox was the most sensitive to latex protease than other mammal's blood. Concomitantly, the plant latex protease could significantly reduce whole blood clotting time of human and mice blood samples.
CONCLUSION: The protease fraction of latices of Euphorbia nivulia, Pedilanthus tithymaloides and Synadenium grantii possesses phytoconstituents capable of arresting wound bleeding, and accelerating whole blood coagulation process. It suggests good potentiality for use of latex proteases in wound management. Also, the finding of this study showed that the protease enzyme of Pedilanthus tithymaloides has the most potent hemostatic agent.
© 2013 Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Blood clotting; Copper sulfate (PubChem CID: 24462); Ethylenediaminetetraacetic acid (PubChem CID: 57339238); Hemostatic agent; Hydrochloric acid (PubChem CID: 313); Iodoacetic acid (PubChem CID: 5240); Latex; Laticiferous plant; Mercuric chloride (PubChem CID: 24085); Pepstatin A (PubChemCID: 5478883); Phenylmethylsulfonyl fluoride (PubChem CID: 4784); Potassium sodium tartrate (PubChem CID: 9855836); Sodium chloride (PubChem CID: 5234); Sulfuric acid (PubChem CID: 1118)

Mesh:

Substances:

Year:  2013        PMID: 24291032     DOI: 10.1016/j.jep.2013.11.044

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  3 in total

Review 1.  Production of Plant Proteases and New Biotechnological Applications: An Updated Review.

Authors:  Franco David Troncoso; Daniel Alberto Sánchez; María Luján Ferreira
Journal:  ChemistryOpen       Date:  2022-03       Impact factor: 2.630

Review 2.  Platelets: still a therapeutical target for haemostatic disorders.

Authors:  Reinaldo Barros Geraldo; Plínio Cunha Sathler; André Luiz Lourenço; Max Seidy Saito; Lucio M Cabral; Pabulo Henrique Rampelotto; Helena Carla Castro
Journal:  Int J Mol Sci       Date:  2014-10-07       Impact factor: 5.923

3.  Potential Health Risks of Macro- and Microelements in Commercial Medicinal Plants Used to Treatment of Diabetes.

Authors:  Igor D de Souza; Elaine S P Melo; Valdir Aragão Nascimento; Hugo S Pereira; Kassia R N Silva; Paulo R Espindola; Paula F S Tschinkel; Eliza M Ramos; Francisco J M Reis; Iara B Ramos; Fernanda G Paula; Karla R W Oliveira; Cleberson D Lima; Ângela A Nunes; Valter Aragão do Nascimento
Journal:  Biomed Res Int       Date:  2021-03-31       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.